The adjuvant AlhydroGel elicits higher antibody titres than AddaVax when combined with HIV-1 subtype C gp140 from CAP256
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The adjuvant AlhydroGel elicits higher antibody titres than AddaVax when combined with HIV-1 subtype C gp140 from CAP256
Authors
Keywords
Antibodies, Enzyme-linked immunoassays, Immunologic adjuvants, Antigens, Antibody response, HIV-1, Vaccines, Immune response
Journal
PLoS One
Volume 13, Issue 12, Pages e0208310
Publisher
Public Library of Science (PLoS)
Online
2018-12-18
DOI
10.1371/journal.pone.0208310
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Effects of Adjuvants on HIV-1 Envelope Glycoprotein SOSIP Trimers In Vitro
- (2018) Gabriel Ozorowski et al. JOURNAL OF VIROLOGY
- Elicitation of Robust Tier 2 Neutralizing Antibody Responses in Nonhuman Primates by HIV Envelope Trimer Immunization Using Optimized Approaches
- (2017) Matthias Pauthner et al. IMMUNITY
- The quest for an antibody-based HIV vaccine
- (2017) Barton F. Haynes et al. IMMUNOLOGICAL REVIEWS
- Use of broadly neutralizing antibodies for HIV-1 prevention
- (2017) Amarendra Pegu et al. IMMUNOLOGICAL REVIEWS
- Native-like Env trimers as a platform for HIV-1 vaccine design
- (2017) Rogier W. Sanders et al. IMMUNOLOGICAL REVIEWS
- An HIV Vaccine Is Essential for Ending the HIV/AIDS Pandemic
- (2017) Anthony S. Fauci JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Randomized, Double-Blind Evaluation of Late Boost Strategies for HIV-Uninfected Vaccine Recipients in the RV144 HIV Vaccine Efficacy Trial
- (2017) Supachai Rerks-Ngarm et al. JOURNAL OF INFECTIOUS DISEASES
- Developing an HIV vaccine
- (2017) Barton F. Haynes et al. SCIENCE
- Trispecific broadly neutralizing HIV antibodies mediate potent SHIV protection in macaques
- (2017) Ling Xu et al. SCIENCE
- What Are the Most Powerful Immunogen Design Vaccine Strategies?
- (2017) Dennis R. Burton Cold Spring Harbor Perspectives in Biology
- Adjuvants
- (2017) M. Juliana McElrath Current Opinion in HIV and AIDS
- HIV-1-neutralizing antibody induced by simian adenovirus- and poxvirus MVA-vectored BG505 native-like envelope trimers
- (2017) Silvia Capucci et al. PLoS One
- Combination HIV prevention options for young women in Africa
- (2016) Cheryl Baxter et al. AJAR-African Journal of AIDS Research
- HIV-Host Interactions: Implications for Vaccine Design
- (2016) Barton F. Haynes et al. Cell Host & Microbe
- Germinal Center B Cell and T Follicular Helper Cell Responses to Viral Vector and Protein-in-Adjuvant Vaccines
- (2016) Chuan Wang et al. JOURNAL OF IMMUNOLOGY
- Adjuvant-dependent innate and adaptive immune signatures of risk of SIVmac251 acquisition
- (2016) Monica Vaccari et al. NATURE MEDICINE
- Approaches to the induction of HIV broadly neutralizing antibodies
- (2016) Penny L. Moore et al. Current Opinion in HIV and AIDS
- Direct Probing of Germinal Center Responses Reveals Immunological Features and Bottlenecks for Neutralizing Antibody Responses to HIV Env Trimer
- (2016) Colin Havenar-Daughton et al. Cell Reports
- Broad HIV-1 inhibition in vitro by vaccine-elicited CD8+ T cells in African adults
- (2016) Gaudensia Mutua et al. Molecular Therapy-Methods & Clinical Development
- Lessons from the RV144 Thai Phase III HIV-1 Vaccine Trial and the Search for Correlates of Protection
- (2015) Jerome H. Kim et al. Annual Review of Medicine
- Dissecting Polyclonal Vaccine-Induced Humoral Immunity against HIV Using Systems Serology
- (2015) Amy W. Chung et al. CELL
- Identification of Common Features in Prototype Broadly Neutralizing Antibodies to HIV Envelope V2 Apex to Facilitate Vaccine Design
- (2015) Raiees Andrabi et al. IMMUNITY
- Antigenicity and Immunogenicity of a Trimeric Envelope Protein from an Indian Clade C HIV-1 Isolate
- (2015) Rangasamy Sneha Priya et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Viral variants that initiate and drive maturation of V1V2-directed HIV-1 broadly neutralizing antibodies
- (2015) Jinal N Bhiman et al. NATURE MEDICINE
- Structures of HIV-1 Env V1V2 with broadly neutralizing antibodies reveal commonalities that enable vaccine design
- (2015) Jason Gorman et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Structures of HIV-1 Env V1V2 with broadly neutralizing antibodies reveal commonalities that enable vaccine design
- (2015) Jason Gorman et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Cleavage-Independent HIV-1 Env Trimers Engineered as Soluble Native Spike Mimetics for Vaccine Design
- (2015) Shailendra Kumar Sharma et al. Cell Reports
- Nonneutralizing Functional Antibodies: a New “Old” Paradigm for HIV Vaccines
- (2014) Jean-Louis Excler et al. Clinical and Vaccine Immunology
- Developmental pathway for potent V1V2-directed HIV-neutralizing antibodies
- (2014) Nicole A. Doria-Rose et al. NATURE
- Stable, uncleaved HIV-1 envelope glycoprotein gp140 forms a tightly folded trimer with a native-like structure
- (2014) James M. Kovacs et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Vaccine-elicited primate antibodies use a distinct approach to the HIV-1 primary receptor binding site informing vaccine redesign
- (2014) K. Tran et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Squalene-adjuvanted H7N9 virus vaccine induces robust humoral immune response against H7N9 and H7N7 viruses
- (2014) Chia-Ying Wu et al. VACCINE
- Multiple Pathways of Escape from HIV Broadly Cross-Neutralizing V2-Dependent Antibodies
- (2013) P. L. Moore et al. JOURNAL OF VIROLOGY
- Vaccine-elicited Human T Cells Recognizing Conserved Protein Regions Inhibit HIV-1
- (2013) Nicola Borthwick et al. MOLECULAR THERAPY
- Supersite of immune vulnerability on the glycosylated face of HIV-1 envelope glycoprotein gp120
- (2013) Leopold Kong et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Cleavage strongly influences whether soluble HIV-1 envelope glycoprotein trimers adopt a native-like conformation
- (2013) R. P. Ringe et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The adjuvant effect of MF59 is due to the oil-in-water emulsion formulation, none of the individual components induce a comparable adjuvant effect
- (2013) Samuele Calabro et al. VACCINE
- Immune-Correlates Analysis of an HIV-1 Vaccine Efficacy Trial
- (2012) Barton F. Haynes et al. NEW ENGLAND JOURNAL OF MEDICINE
- Broadly neutralizing antibodies against HIV-1: Templates for a vaccine
- (2012) Marit J. van Gils et al. VIROLOGY
- Structure of HIV-1 gp120 V1/V2 domain with broadly neutralizing antibody PG9
- (2011) Jason S. McLellan et al. NATURE
- The porcine circovirus type 1 capsid gene promoter improves antigen expression and immunogenicity in a HIV-1 plasmid vaccine
- (2011) Fiona L Tanzer et al. Virology Journal
- Vaccination with ALVAC and AIDSVAX to Prevent HIV-1 Infection in Thailand
- (2009) Supachai Rerks-Ngarm et al. NEW ENGLAND JOURNAL OF MEDICINE
- Vaccines: Correlates of Vaccine‐Induced Immunity
- (2008) Stanley A. Plotkin CLINICAL INFECTIOUS DISEASES
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now